![logo](/logos/ALM.MC.webp)
Almirall, S.A.
MSE:ALM.MC
8.57 (EUR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Almirall, S.A. |
Symbool | ALM.MC |
Munteenheid | EUR |
Prijs | 8.57 |
Beurswaarde | 1,829,429,330 |
Dividendpercentage | 0% |
52-weken bereik | 7.85 - 10.08 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Carlos Gallardo Piqué |
Website | https://www.almirall.com |
An error occurred while fetching data.
Over Almirall, S.A.
Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)